EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 167 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $222,000 | +11000.0% | 5,414 | +17364.5% | 0.00% | – |
Q2 2021 | $2,000 | -97.6% | 31 | -96.6% | 0.00% | – |
Q1 2021 | $84,000 | -82.7% | 909 | -83.2% | 0.00% | -100.0% |
Q4 2020 | $486,000 | -83.5% | 5,425 | -81.0% | 0.00% | -83.3% |
Q3 2020 | $2,952,000 | +1993.6% | 28,574 | +1499.9% | 0.02% | +1700.0% |
Q2 2020 | $141,000 | +291.7% | 1,786 | +182.6% | 0.00% | – |
Q1 2020 | $36,000 | -76.0% | 632 | -77.2% | 0.00% | -100.0% |
Q4 2019 | $150,000 | -20.2% | 2,777 | -22.8% | 0.00% | 0.0% |
Q3 2019 | $188,000 | -45.3% | 3,597 | -49.6% | 0.00% | -50.0% |
Q2 2019 | $344,000 | -97.1% | 7,131 | -97.0% | 0.00% | -96.2% |
Q1 2019 | $11,908,000 | +1.7% | 235,700 | +19.3% | 0.05% | -3.6% |
Q4 2018 | $11,711,000 | -8.5% | 197,557 | +1.6% | 0.06% | +14.6% |
Q3 2018 | $12,799,000 | +67.7% | 194,422 | +28.6% | 0.05% | +60.0% |
Q2 2018 | $7,633,000 | +1.2% | 151,188 | +5.6% | 0.03% | 0.0% |
Q1 2018 | $7,541,000 | +22.1% | 143,238 | +7.7% | 0.03% | +30.4% |
Q4 2017 | $6,178,000 | +1304.1% | 132,948 | +1123.2% | 0.02% | +1050.0% |
Q3 2017 | $440,000 | -49.7% | 10,869 | -57.9% | 0.00% | -50.0% |
Q2 2017 | $875,000 | -83.0% | 25,817 | -85.4% | 0.00% | -81.0% |
Q1 2017 | $5,142,000 | -8.0% | 177,076 | +4.0% | 0.02% | -19.2% |
Q4 2016 | $5,589,000 | -24.2% | 170,185 | -27.2% | 0.03% | -25.7% |
Q3 2016 | $7,374,000 | +91.3% | 233,880 | +70.6% | 0.04% | +84.2% |
Q2 2016 | $3,854,000 | -19.1% | 137,069 | +4.6% | 0.02% | -20.8% |
Q1 2016 | $4,763,000 | -9.2% | 131,032 | 0.0% | 0.02% | -7.7% |
Q4 2015 | $5,243,000 | +233.3% | 131,032 | +137.4% | 0.03% | +225.0% |
Q3 2015 | $1,573,000 | +9.2% | 55,203 | +26.2% | 0.01% | +14.3% |
Q2 2015 | $1,441,000 | +3692.1% | 43,744 | +3221.5% | 0.01% | – |
Q1 2015 | $38,000 | -85.2% | 1,317 | -86.1% | 0.00% | -100.0% |
Q4 2014 | $257,000 | +162.2% | 9,454 | +106.4% | 0.00% | – |
Q3 2014 | $98,000 | -98.2% | 4,580 | -98.1% | 0.00% | -100.0% |
Q2 2014 | $5,329,000 | -28.7% | 237,246 | -19.8% | 0.03% | -25.7% |
Q1 2014 | $7,476,000 | +45.3% | 295,834 | +32.2% | 0.04% | +45.8% |
Q4 2013 | $5,144,000 | – | 223,770 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |